Breast cancer care across CION centres in Hyderabad · ArogyaSri, CGHS & cashless insurance accepted · Call 1800 202 8726

During treatment

How response is monitored during neoadjuvant chemotherapy

Response is tracked mostly by examining the breast before every cycle and measuring what can be felt, with a scan usually added partway through the course. The real answer comes from the tissue removed at surgery. This page explains each check, what triggers a change of plan, and why nothing before surgery counts as proof.

Call 1800 202 8726

Speak to an oncologist

Book a consultation

Talk to a breast cancer specialist at a CION centre near you.

Free call back. Your details stay private.

NG
Medically reviewed by Dr. Naresh GunduConsultant Medical Oncologist · MBBS, DNB (Internal Medicine), DM (Medical Oncology, AIIMS) · last reviewed September 2026, next review due September 2027
17+specialists on panel
15,000+patients treated
35+centres across Telangana & AP
4.8★ / 800+Google rating

The short answer

How do they know the chemotherapy is working?

Mostly by examining the breast before every cycle and measuring what can be felt. A scan is usually added partway through the course, and sometimes another near the end. The removed tissue at surgery gives the real answer, and everything before that is an estimate.

Why the hands-on examination matters most

It happens most often. Your oncologist feels the lump before each cycle and records its size, so a trend builds up over months rather than resting on one picture. A lump that is softening and shrinking cycle by cycle is the most reassuring thing in this whole process.

What the scan adds

It sees what the hand cannot, particularly for cancers sitting deep in the breast and for the lymph nodes in the armpit. It is also the only way to judge response where the lump was never easy to feel in the first place.

The methods

What is used to track the response

Each has a different job, and none of them is the final word.

Clinical examination

Before every cycle. Quick, free, and repeated often enough to show a trend. Ask what the measurement was and whether it has changed since last time.

Ultrasound

The usual choice for a mid-treatment check. It is quick, involves no radiation, and measures both the breast lump and the nodes in the armpit.

Good for

  • Measuring a shrinking lump
  • Watching the armpit nodes
  • Repeating often without concern

MRI

The most accurate picture of how much disease remains, used where the answer will change the operation. Not every centre uses it routinely, and it is not needed for everyone.

Ask whether an MRI would change your surgery.

Your own observation

Many women feel the lump softening before anyone measures a difference. Tell your team what you are noticing, including if you think it is getting larger. You are not being a nuisance.

Not sure whether this applies to you?

Ask an oncologist

The schedule

When each check usually happens

  1. Before the first cycle

    The starting measurements are recorded, and a marker clip is placed in the tumour. Everything later is compared against this point, so ask for the starting size to be written down.

  2. Before each cycle

    An examination of the breast and armpit, alongside the blood tests that decide whether the cycle goes ahead. This is where most of the monitoring actually happens.

  3. Around the midpoint

    Usually a scan, most often an ultrasound. This is the formal check on whether the plan should continue unchanged, and the point at which a change of drugs would be considered.

  4. Near the end of the course

    A further scan in many centres, to plan the operation. It maps what is left and where it sits, which determines how much tissue has to come out.

  5. At surgery

    The tissue removed is examined under a microscope. This is the only assessment that counts as the answer, and it is the reason the whole approach was chosen.

Words you will hear

The vocabulary, in plain language

Partial response
The cancer has shrunk meaningfully but is still there. This is a good result and the most common one.
Stable disease
Not obviously smaller, not obviously bigger. It prompts a discussion rather than an immediate change.
Progression
The cancer has grown during treatment. Uncommon, and it does lead to a change of plan.
Clinical complete response
Nothing can be felt or seen on a scan. Encouraging, but microscopic cancer very often remains, so surgery still goes ahead.
Marker clip
The tiny clip placed in the tumour before treatment, so the site can be found even if the lump disappears.
Interval assessment
The formal mid-treatment check, usually a scan plus examination.

Leave a number, we will call you

One field. No form to fill in, and no charge for the call.

Talk to our team

Have a question about your situation?

Call the helpline or leave your details, and someone will help you arrange a consultation at the CION centre nearest you. One helpline serves every CION centre.

Call 1800 202 8726 Helpline open 24/7

Request a call back

Share your number and a specialist's team will call you.

Free call back. Your details stay private.

Side by side

What each finding usually leads to

What the check shows What usually happens
Clearly shrinking Continue the plan unchanged
Shrinking slowly Usually continue, with a further check sooner
No clear change Discussed at the tumour board; drugs may be switched
Growing during treatment The plan changes, often to different drugs or earlier surgery
Nothing left to feel or see Surgery still goes ahead, guided by the marker clip

Being straight with you

What the monitoring cannot tell you

No scan or examination during treatment can tell you how much cancer is actually left. Both routinely overestimate and underestimate. Only the tissue removed at surgery settles it, which is why surgery goes ahead even when everything looks clear.

Why measurements bounce around

A lump is measured by different people, sometimes on different machines, and swelling from the treatment itself can make an area feel larger than the cancer within it. A small change between two measurements is often noise rather than news.

Feeling nothing is not proof

A clinical complete response is genuinely encouraging, but microscopic cancer remains in a substantial number of women whose lump has disappeared entirely. This is the single most common misunderstanding of this stage, and the reason surgery is never cancelled on the strength of it.

What to ask at each visit

What was the measurement today, how does it compare with last time, and is the plan unchanged. Three short questions, asked every cycle, give you a clearer picture than any single scan report.

Commonly believed

What families assume about the checks

If the lump has gone, surgery can be cancelled.

Microscopic cancer very often remains where the lump can no longer be felt, and no scan can rule that out. Surgery is what confirms the response and removes what is left. This is why the marker clip was placed before treatment began.

No scan this month means nobody is watching.

The examination before every cycle is the main monitoring, and it happens far more often than scanning would. Scans are added at points where the answer would change something. Ask what today's examination showed and you will see the tracking is there.

Slow shrinking means the drugs are wrong.

Different subtypes respond at very different speeds, and hormone sensitive cancers in particular shrink slowly. Steady, modest shrinking over several cycles is a normal and acceptable response, not a reason to change course.

We should pay for a PET-CT to be certain.

It is not more reliable for judging response in the breast, and it finds harmless bright areas often enough to start a chain of further tests. If you want more certainty, ask whether an MRI would change your operation, which is a question with a real answer.

Questions we are asked

Common questions about monitoring the response

How soon should I expect to feel a difference?

Many women notice softening within the first two or three cycles, though it varies a great deal by subtype. Triple negative and HER2 positive cancers often respond visibly and quickly. Hormone sensitive cancers shrink slowly, and that is expected rather than disappointing.

Will I be told the measurements?

Usually only if you ask, because the team is tracking a trend rather than reporting each figure. Ask for the number at each visit and note it down yourself. Seeing your own list of measurements is more reassuring than any single conversation.

Should I ask for an MRI?

Ask whether it would change your operation. If the answer is yes, it is a reasonable request. If your surgery plan is already settled regardless, the scan adds cost and waiting without changing anything your team will do.

The lump feels bigger. Should I be worried?

Tell your team this week rather than waiting for the next cycle. It is often swelling from the treatment rather than growth, but genuine progression does need acting on quickly. This is exactly the kind of thing you should report without hesitating.

Do the nodes in my armpit get checked too?

Yes, both by examination and on the ultrasound. Nodes that were involved at the start and have become normal is a good sign, and it may reduce how much armpit surgery you need. Ask specifically what the nodes are doing.

What if the scan result and the examination disagree?

It happens, and neither is definitive. Your team reads them together, alongside the trend over several cycles. Where the disagreement matters for surgery, an MRI or a discussion at the tumour board usually settles the plan.

Does a blood test show whether it is working?

Not usefully in early breast cancer. The blood tests before each cycle check whether your body can safely take the treatment, not whether the cancer is responding. Tumour marker tests are not used for this purpose here.

Can I see the scan images myself?

Yes, ask the imaging department for copies and ask your oncologist to point out the area on screen. Many women find seeing the change directly does more for their confidence than being told a number.

Meet the Specialists

17+ senior cancer specialists. One panel for your case.

Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.

Dr. Naresh Gundu
Medical Oncologist

Dr. Naresh Gundu

MBBS, DNB (Internal Medicine), DM (Medical Oncology)

View Profile
Dr. C. Raghavendra Reddy
Medical Oncologist

Dr. C. Raghavendra Reddy

MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)

View Profile
Dr. Bharati Devi Gorantla
Medical Oncologist

Dr. Bharati Devi Gorantla

MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)

View Profile
Dr. Owais Mohammed
Medical Oncologist

Dr. Owais Mohammed

MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)

View Profile
Dr. T. Raghavender Reddy
Medical Oncologist

Dr. T. Raghavender Reddy

MBBS, DM (Medical Oncology), MD (Radiation Oncology)

View Profile
Dr. N. Kiranmayee
Medical Oncologist

Dr. N. Kiranmayee

MBBS, DM (Medical Oncology), MD (Internal Medicine)

View Profile
Dr. Muralidhar Muddusetty
Surgical Oncologist

Dr. Muralidhar Muddusetty

MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)

View Profile
Dr. Raghavendra Naik
Surgical Oncologist

Dr. Raghavendra Naik

MBBS, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Mohammed  Imaduddin
Surgical Oncologist

Dr. Mohammed Imaduddin

M.B.B.S, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Vinay Mamidala
Surgical Oncologist

Dr. Vinay Mamidala

MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)

View Profile
Dr. Paila Gowri Naidu
Surgical Oncologist

Dr. Paila Gowri Naidu

MBBS, MS (General Surgery), M.Ch (Surgical Oncology), FMAS

View Profile
Dr. Venkata Sushma P
Radiation Oncologist

Dr. Venkata Sushma P

MBBS, MD (Radiation Oncology)

View Profile
Dr. Kirti Ranjan Mohanty
Radiation Oncologist

Dr. Kirti Ranjan Mohanty

MBBS, MD (Radiation Oncology)

View Profile
Dr. Gangadhar Vajrala
Radiation Oncologist

Dr. Gangadhar Vajrala

MBBS, MD (Radiation Oncology), MPH

View Profile
Dr. Basudev Pokhrel
Hematologist

Dr. Basudev Pokhrel

MBBS, M.D (Immunohematology & Blood Transfusion)

View Profile
Dr. Vajja Sandeep Kumar
Surgical Oncologist

Dr. Vajja Sandeep Kumar

MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology

View Profile
Dr. Sridhar Kamani
Surgical Oncologist

Dr. Sridhar Kamani

MBBS, MS (General Surgery), DrNB (Surgical Oncology)

View Profile

Want a specific doctor for your case? Mention them when booking.

Book Free Consultation

Where to find us

Our centres in and around Hyderabad

Addressed by landmark, because that is how this city navigates. Each centre also names the areas it serves, so you can place it without a map. Consultation and day-care Chemotherapy run at every one of them.

CION Ameerpet

Beside Blue Fox Hotel, Satyam Theatre Road

Begumpet SR Nagar Punjagutta
CION Kukatpally

Opposite Big Bazaar, Mumbai Highway

KPHB JNTU Bharat Nagar
CION L.B. Nagar

Anu Arcade, next to L.B. Nagar Metro station

Vanasthalipuram Nagole Hayathnagar
CION Tolichowki

Inside Premier Hospital, Khader Bagh Road

Mehdipatnam Attapur Rethibowli
CION Masab Tank

Mahavir Hospital, AC Guards, Lakdikapul

Lakdikapul Khairatabad Basheer Bagh
CION Banjara Hills

Road No. 12

Jubilee Hills Madhapur Film Nagar
CION Kompally

Suchitra Circle, NH-44

Suchitra Circle Alwal Dundigal
CION Balanagar

Balanagar Main Road

Balanagar Fatehnagar Moosapet
CION Siddipet

Lohith Sai Hospital, Shivaji Nagar

Gajwel Husnabad Dubbaka
CION Sangareddy

X Roads, Pothreddipalle

Narayankhed Zaheerabad Patancheru

Talk to our team

Speak to a breast cancer specialist

Call the helpline or leave your details, and someone will help you arrange a consultation at the CION centre nearest you. One helpline serves every CION centre.

Call 1800 202 8726 Helpline open 24/7

Request a call back

Share your number and a specialist's team will call you.

Free call back. Your details stay private.

Sources

  1. Cancer Research UK — Chemotherapy before surgery for breast cancer
  2. National Cancer Institute — Neoadjuvant therapy
  3. Breast Cancer Now — Chemotherapy before surgery

This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.

Call 1800 202 8726Book a consultation
Explore more

Breast Cancer Topics

Browse our complete guide to breast cancer — types, symptoms, tests and treatments. Tap any topic to read more.

HER2-Targeted Therapy

Cost of a full year of HER2 therapy in India De-escalated HER2 treatment for small tumours What happens if your heart function drops during treatment? Ejection fraction monitoring on HER2 therapy HER2-low breast cancer HER2-positive and hormone-positive together The full HER2 treatment pathway How does pertuzumab work, and who is it for? How does trastuzumab emtansine work, and who is it for? How long will you be on pertuzumab? Is adding pertuzumab worth the extra cost? Missed a dose of pertuzumab? What to do Missed a dose of trastuzumab emtansine? What to do Neratinib as extended adjuvant HER2 therapy Pertuzumab, fertility, menopause and sexual health How much does pertuzumab actually help? The numbers explained Pertuzumab cost in India Diarrhoea and rash on pertuzumab Heart function monitoring on dual HER2 blockade Pertuzumab infusion day Medicines, foods and supplements to avoid on pertuzumab Tests and monitoring while you are on pertuzumab Pertuzumab myths Pertuzumab (Perjeta) for breast cancer Pertuzumab side effects Pertuzumab T-DM1 infusion day Liver enzyme rises and nerve changes on T-DM1 Low platelets and bleeding risk on T-DM1 T-DM1 myths T-DM1 vs continuing trastuzumab after residual disease Trastuzumab emtansine (T-DM1) after residual disease Trastuzumab biosimilars in India Trastuzumab emtansine, fertility, menopause and sexual health How much does trastuzumab emtansine actually help? The numbers explained Trastuzumab emtansine cost in India Medicines, foods and supplements to avoid on trastuzumab emtansine Trastuzumab emtansine side effects Trastuzumab emtansine (Kadcyla) for breast cancer Lapatinib and tucatinib Why exactly twelve months of trastuzumab?

Hormone Therapy Medicines

Anastrozole, fertility, menopause and sexual health How much does anastrozole actually help? The numbers explained Anastrozole cost in India Medicines, foods and supplements to avoid on anastrozole Cholesterol, bone density and long-term effects of anastrozole Tests and monitoring while you are on anastrozole Anastrozole myths Anastrozole side effects Anastrozole vs tamoxifen Anastrozole (Arimidex) for breast cancer Exemestane, fertility, menopause and sexual health How much does exemestane actually help? The numbers explained Exemestane cost in India Medicines, foods and supplements to avoid on exemestane Joint pain and fatigue on exemestane Tests and monitoring while you are on exemestane Exemestane myths Exemestane side effects Why exemestane is taken after food and its steroidal effects Exemestane (Aromasin) for breast cancer Fulvestrant, fertility, menopause and sexual health How much does fulvestrant actually help? The numbers explained Fulvestrant cost in India Injection site pain and reactions on fulvestrant The fulvestrant injection Medicines, foods and supplements to avoid on fulvestrant Tests and monitoring while you are on fulvestrant Fulvestrant myths Fulvestrant side effects Fulvestrant vs aromatase inhibitors in advanced disease Fulvestrant (Faslodex) for breast cancer How much does goserelin actually help? The numbers explained Bone loss and mood changes on ovarian suppression Goserelin cost in India The goserelin implant Medicines, foods and supplements to avoid on goserelin Sudden menopause symptoms from ovarian suppression Tests and monitoring while you are on goserelin Goserelin myths Goserelin side effects Goserelin injections vs surgical ovary removal Goserelin (Zoladex) for breast cancer Hot flushes, joint pain and fatigue on fulvestrant How does anastrozole work, and who is it for? How does exemestane work, and who is it for? How does fulvestrant work, and who is it for? How does goserelin work, and who is it for? How does letrozole work, and who is it for? Postmenopausal hormone-receptor-positive breast cancer How long will you be on anastrozole? How long will you be on exemestane? How long will you be on fulvestrant? How long will you be on goserelin? How long will you be on letrozole? Taking anastrozole Taking exemestane Taking letrozole Letrozole, fertility, menopause and sexual health How much does letrozole actually help? The numbers explained Bone thinning on letrozole Letrozole cost in India Medicines, foods and supplements to avoid on letrozole Joint pain and morning stiffness on letrozole Tests and monitoring while you are on letrozole Letrozole myths Letrozole side effects Letrozole vs anastrozole vs exemestane Letrozole (Femara) for breast cancer Missed a dose of anastrozole? What to do Missed a dose of exemestane? What to do Missed a dose of fulvestrant? What to do Missed a dose of goserelin? What to do Missed a dose of letrozole? What to do Exemestane after letrozole or anastrozole Will your periods and fertility return after stopping goserelin?

Targeted & Newer Medicines

Abemaciclib, fertility, menopause and sexual health How much does abemaciclib actually help? The numbers explained Abemaciclib cost in India Diarrhoea on abemaciclib Two years of abemaciclib after surgery Medicines, foods and supplements to avoid on abemaciclib Tests and monitoring while you are on abemaciclib Abemaciclib myths Abemaciclib side effects Abemaciclib vs other CDK4/6 inhibitors Abemaciclib (Verzenio) for breast cancer CDK4/6 inhibitors in early breast cancer after surgery Adjuvant olaparib after surgery for BRCA carriers Alpelisib, fertility, menopause and sexual health How much does alpelisib actually help? The numbers explained Alpelisib cost in India High blood sugar on alpelisib Medicines, foods and supplements to avoid on alpelisib Tests and monitoring while you are on alpelisib Alpelisib myths Alpelisib (Piqray) for breast cancer Rash and mouth sores on alpelisib Alpelisib side effects Alpelisib vs everolimus after endocrine therapy fails Alpelisib for PIK3CA-mutated breast cancer CDK4/6 inhibitors in breast cancer Everolimus in hormone-resistant breast cancer How does abemaciclib work, and who is it for? How does ribociclib work, and who is it for? How does sacituzumab govitecan work, and who is it for? How long will you be on alpelisib? How long will you be on ribociclib? How long will you be on sacituzumab govitecan? Taking abemaciclib Taking alpelisib Taking ribociclib Liquid biopsy in metastatic breast cancer Missed a dose of abemaciclib? What to do Missed a dose of alpelisib? What to do Missed a dose of ribociclib? What to do Missed a dose of sacituzumab govitecan? What to do Newer drugs Elacestrant and oral SERDs for ESR1-mutant disease PARP inhibitors for BRCA-mutated breast cancer Do you need a PIK3CA test before alpelisib? Ribociclib, fertility, menopause and sexual health How much does ribociclib actually help? The numbers explained Ribociclib cost in India ECG monitoring and QT prolongation on ribociclib Medicines, foods and supplements to avoid on ribociclib Low white cell counts on ribociclib Tests and monitoring while you are on ribociclib Ribociclib myths Ribociclib side effects Ribociclib (Kisqali) for breast cancer Sacituzumab govitecan, fertility, menopause and sexual health How much does sacituzumab govitecan actually help? The numbers explained Sacituzumab govitecan cost and availability in India Diarrhoea on sacituzumab govitecan and how it is managed Medicines, foods and supplements to avoid on sacituzumab govitecan Tests and monitoring while you are on sacituzumab govitecan Sacituzumab govitecan myths Low counts, fever risk and hair loss on sacituzumab govitecan Sacituzumab govitecan infusion days Sacituzumab govitecan side effects Sacituzumab govitecan for triple-negative breast cancer Sacituzumab govitecan vs standard chemotherapy in triple negative breast cancer How newer drugs are sequenced with older ones

Metastatic Breast Cancer

What comes after a CDK4/6 inhibitor stops working? Ascites and abdominal swelling in advanced breast cancer Is my back pain bone metastasis or something else? Bone marrow involvement in advanced breast cancer Bone metastases in breast cancer Brain metastases in breast cancer Tumour markers CA 15-3 and CEA in metastatic breast cancer Chest wall and local recurrence after mastectomy Clinical trials in metastatic breast cancer Cost of long-term metastatic breast cancer treatment in India Explaining metastatic breast cancer to family and friends First-line treatment for hormone-positive metastatic breast cancer Confusion, thirst and drowsiness Lines of treatment in metastatic breast cancer Liver metastases in breast cancer Living well with metastatic breast cancer for years Lung metastases and pleural effusion in breast cancer Malignant pleural effusion Metastatic breast cancer and pink-ribbon culture Prognosis in metastatic breast cancer Treatment sequence in metastatic HER2-positive breast cancer Treatment options in metastatic triple negative breast cancer Oligometastatic breast cancer Why receptors are re-tested on a metastatic biopsy Scan intervals and monitoring in metastatic disease Understanding scan reports in metastatic breast cancer Skin metastases and nodules on the chest Surgery and radiation in metastatic breast cancer Treatment holidays and breaks in metastatic breast cancer When do doctors switch treatment in metastatic disease? Where breast cancer spreads and what each site feels like Working and earning with metastatic breast cancer
Call now Book free consultation